Cerestat: Began a Phase III trial of Cerestat in patients with traumatic brain injury (TBI).

The primary end point is performance on the Glasgow Outcome Score, a standard measure of clinical outcome after neurological injury. Secondary end points will include disability and pharmacoeconomic measures. ...